一个随机的前性调查,针对知识,障碍,促进者和参与痴呆症研究的准备
M Sajatovic1, L K Herrmann, C Knebusch
1Martha Sajatovic, M.D., Professor of Psychiatry and of Neurology, Case Western Reserve University School of Medicine, Director, Neurological and Behavioral Outcomes Center, University Hospitals Cleveland Medical Center, 10524 Euclid Avenue, Cleveland, Ohio 44106, Tel. 216/844-2808, Fax 216/844-2742,
The journal of prevention of Alzheimer's disease
|October 24, 2023
概括
一项新的沟通战略 (POWER) 减少了少数群体参与痴呆症研究的障碍. 虽然痴呆症知识在对照组中增加了更多,但POWER显示了改善非裔美国人研究准备的潜力.
科学领域:
- 老年学和阿尔茨海默病的研究研究.
- 卫生传播策略 卫生传播策略
- 临床研究中的健康差异
背景情况:
- 少数群体在痴呆症研究中的代表性仍然不足,尽管国家都在努力.
- 针对不同社区的招聘策略的现有证据基础有限.
- 这项研究评估了一种新的沟通方法,以解决参与障碍.
研究的目的:
- 测试一种概念驱动的沟通方法 (POWER),针对研究参与与标准教育的障碍和促进者.
- 为了比较POWER干预的有效性与积极的比较对照.
- 评估痴呆知识的变化,感知障碍,促进者和研究准备.
主要方法:
- 一个两阶段项目,涉及少数派顾问委员会的投入.
- 开发两个健康传播视频:权力 (障碍物/促进者) 和教育控制.
- 在第2阶段的一项随机前性调查,将POWER与活性对照进行比较,使用重复测量ANOVA.
主要成果:
- 权力干预显著降低了对痴呆症研究的感知障碍 (p=.044).
- 对照组显示,痴呆症知识的增加更大 (p=0.004).
- 在研究促进者或团体之间的准备程度上没有发现任何显著差异,尽管非洲裔美国人之间的趋势有利于权力.
结论:
- 针对特定的障碍和态度可以为加强痴呆症研究参与的策略提供信息.
- "权力"方法显示了改善不同社区参与的潜力.
- 需要进一步的研究来优化临床试验中代表性不足的群体的沟通策略.
更多相关视频
相关概念视频
Dementia
120
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
120
Surveys
14.8K
Often, psychologists develop surveys as a means of gathering data. Surveys are lists of questions to be answered by research participants, and can be delivered as paper-and-pencil questionnaires, administered electronically, or conducted verbally. Generally, the survey itself can be completed in a short time, and the ease of administering a survey makes it easy to collect data from a large number of people.
14.8K
Alzheimer's Disease: Overview
500
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
500


